Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1017445

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Zoledronic Acid
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that there is equality geographically in the availability of Zoledronic acid for breast cancer treatment.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	197655
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Decisions on the routine availability of medicines, such as Zoledronic acid, are made locally by clinical commissioning groups (CCGs). CCGs make funding decisions based on the needs of their population. Commissioning is about getting the best possible health outcomes for the local population and this involves assessing local needs to inform priorities and strategies.</p><p> </p><p>Under their terms of service, clinicians are allowed to prescribe any product which they consider to be a medicine necessary for the treatment of their patients under the National Health Service, subject to two provisos: firstly, that the product is not included in Schedules 1 or 2 to the NHS (General Medical Services Contracts)(Prescription of Drugs etc.) Regulations 2004 and secondly, that the clinician is prepared to justify any challenges to their prescribing by their local CCG.</p><p> </p><p>Decisions on whether to routinely fund medicines should be taken in the context of the CCGs available resources to ensure that care is fairly allocated to all patients and, where appropriate, measured against the CCGs other service development priorities.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:47:52 answering member 4067 label Biography information for Steve Brine
tabling member	1538 label Biography information for Rosie Cooper

1017449

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans for blood glucose testing strips and needles to remain available by prescription.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	197624
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>This is a matter for NHS England, working in partnership with NHS Clinical Commissioners to support clinical commissioning groups to use their prescribing resources effectively in the interests of their local population.</p><p> </p><p>NHS England has launched a public consultation on proposals to update and review commissioning guidance on eight products, which includes blood glucose testing strips for type 2 diabetes and needles for pre-filled and re-useable insulin pens. The consultation runs from 28 November 2018 until 28 February 2019. Details of how to respond and attend the public consultation events can be found at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:40:09 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

1017491

registered interest
date	30/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of the introduction of a target for patients with pancreatic cancer to receive treatment within 20 days of diagnosis.
tabling member constituency	Oxford West and Abingdon
tabling member printed	Layla Moran
uin	197646
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>The Prime Minister announced the Government’s ambitions to see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these targets, we will need to make significant progress on survival across all cancers, including pancreatic cancer. NHS England will shortly be introducing a Faster Diagnostic Standard of 28 days for all cancer patients which, when taken together with the 62-day referral to treatment standard, will mean that all patients should expect to start their treatment within 34 days of diagnosis. This is a maximum, and trusts should continue to treat patients more quickly particularly where there is a strong clinical need.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:46:57 answering member 4067 label Biography information for Steve Brine
tabling member	4656 label Biography information for Layla Moran

1017187

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bisphosphonates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress NICE has made in updating its guidance on the use of adjuvant bisphosphonates.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	197353
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) updated its guidance on ‘Early and locally advanced breast cancer: diagnosis and management’ in July 2018. The use of adjuvant bisphosphonates was one of the key areas that was covered in the update. NICE’s updated recommendations can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ng101/chapter/Recommendations#bisphosphonate-therapy" target="_blank">https://www.nice.org.uk/guidance/ng101/chapter/Recommendations#bisphosphonate-therapy</a></p><p> </p><p>The guideline recommends bisphosphonates as adjuvant therapy for postmenopausal women with node positive invasive breast cancer and for postmenopausal women with node negative breast cancer.</p><p> </p><p>NICE also updated its guidance on the use of bisphosphonates for treating osteoporosis in February 2018. The updated guidance can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/ta464" target="_blank">https://www.nice.org.uk/guidance/ta464</a></p><p> </p><p>NICE recommends oral bisphosphonates for treating osteoporosis in adults if the person is eligible for risk assessment and the 10 year probability of osteoporotic fragility fracture is at least 1%.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:24:58 answering member 4067 label Biography information for Steve Brine previous answer version 90056 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

1017220

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the (a) effectiveness and (b) trends in the level of use of pre-exposure prophylaxis to reduce HIV infections.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	197463
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Pre-exposure prophylaxis (PrEP) for HIV has been shown to be an effective intervention to reduce the risk of HIV infection. A randomised controlled trial of PrEP in the United Kingdom found an 86% reduction in the risk of HIV infection in gay, bisexual and other men who have sex with men prescribed PrEP. A finding supported by data from New South Wales in Australia where a rapid decline in HIV diagnoses was seen in the 12 months following the introduction of PrEP.</p><p> </p><p>With the development of internet self-purchasing in 2015, PrEP use in England is thought to have quadrupled during 2016 so that an estimated 3,000 gay and bisexual men were taking PrEP by year end. It is probable that this scale-up of PrEP use will have had an effect at reducing underlying HIV incidence, additional to the effect of intensified HIV testing and the immediate treatment of those newly diagnosed as living with HIV. However, it is too soon to estimate the size of this additional effect from available data. The HIV PrEP Impact trial funded by NHS England began in October 2017 to understand questions on PrEP eligibility, uptake and duration of use, and impact on HIV and other sexually transmitted infections.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:46:13 answering member 4067 label Biography information for Steve Brine previous answer version 90057 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4510 label Biography information for Helen Hayes

1017231

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to update the form used to obtain free prescriptions to include an option for universal credit.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	197385
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Work is ongoing to update the FP10 prescription form to include a new exemption tick box for use by Universal Credit claimants who meet the criteria for free National Health Service prescriptions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:43:19 answering member 4067 label Biography information for Steve Brine previous answer version 90059 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1017235

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the number of prescription fines issued in universal credit and legacy benefit areas.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	197386
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Universal Credit and income-based Jobseeker’s Allowance claimants, who are eligible for free National Health Service prescriptions, are both ticking exemption box K on the FP10 prescription form at present. Therefore, the NHS Business Services Authority does not have a data split that would enable such a comparative assessment to be made.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:44:03 answering member 4067 label Biography information for Steve Brine previous answer version 90062 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1017236

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has provided to (a) GP surgeries and (b) pharmacies on the use of prescription forms that do not include a tick box for universal credit.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	197387
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>Completion of the FP10 prescription form, including any declaration of exemption from paying prescription charges, is the responsibility of the patient. Universal Credit claimants who meet the criteria for free National Health Service prescriptions, should tick box K for income-based Jobseeker’s Allowance on the patient declaration until the prescription form is updated to include a tick box for Universal Credit. Advice on this matter is available on the websites for the NHS Business Services Authority and the Pharmaceutical Services Negotiating Committee and accessible to dispensing doctors and pharmacists.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:45:22 answering member 4067 label Biography information for Steve Brine previous answer version 90060 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	3973 label Biography information for Grahame Morris

1017285

registered interest
date	29/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Take-up
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the effect of anti-vaccination groups on vaccination take-up.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	197411
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>The United Kingdom has one of the most comprehensive vaccination programmes in Europe with high uptake. Parental confidence in the immunisation programme is monitored through annual surveys. In 2018, 93% of parents in England expressed confidence in the programme. The vast majority of parents believed immunisations to be safe and effective and have their children immunised when due.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:44:43 answering member 4067 label Biography information for Steve Brine previous answer version 90061 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
tabling member	4425 label Biography information for Jo Stevens

1015359

registered interest
date	27/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much additional funding announced in Budget 2018 has been allocated to the prevention of Type 2 diabetes.
tabling member constituency	Leicester East
tabling member printed	Keith Vaz
uin	196310
answer	answer is ministerial correction date of answer 05/12/2018 answer text <p>The 2018 Budget re-confirms the Prime Minister’s announcement in June this year to work with the National Health Service to develop a 10-year plan for the future of the health service, underpinned by a five-year funding offer which will see the NHS budget grow by £20.5 billion a year in real terms by 2023-24. We expect the plan to be published later this year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/12/2018 16:28:57 answering member 4067 label Biography information for Steve Brine
tabling member	338 label Biography information for Keith Vaz